Profil
F.
Allan Gordon worked as the Chief Executive Officer at Nile Therapeutics, Inc. and as the Medical Director-Scandinavia at Bristol Myers Squibb Co. He also held the position of Senior Director-Clinical Research at Scios, Inc. and Vice President-Clinical at XOMA Corp.
He was the Senior Vice President-Clinical Development at Resverlogix Corp.
for six years.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Dr. Gordon earned a doctorate degree from Karolinska Institutet.
Ehemalige bekannte Positionen von F. Allan Gordon
Unternehmen | Position | Ende |
---|---|---|
XOMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 |
RESVERLOGIX CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Karolinska Institutet | Corporate Officer/Principal | - |
Ausbildung von F. Allan Gordon
Karolinska Institutet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
RESVERLOGIX CORP. | Health Technology |
XOMA CORPORATION | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 2 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |